Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Leukemia|March 13, 2024
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines CommitteeDonal P McLornan, Tomasz Czerw, Gandhi Damaj, et al.
Frontiers in Immunology|February 5, 2021
Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid LeukemiaJohannes Schetelig, Henning Baldauf, Linda Koster, et al.
British Journal of Haematology|April 4, 2017
Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationFrancesco Onida, Liesbeth C de Wreede, Anja van Biezen, et al.
Bone Marrow Transplantation|April 25, 2024
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC)Christian Niederwieser, Simona Iacobelli, Georg-Nikolaus Franke, et al.
Frontiers in Immunology|January 7, 2022
Corrigendum: Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid LeukemiaJohannes Schetelig, Henning Baldauf, Linda Koster, et al.
Bone Marrow Transplantation|March 24, 2020
Treatment of steroid resistant acute graft versus host disease with an anti-CD26 monoclonal antibody-BegelomabAndrea Bacigalupo, Emanuele Angelucci, Anna Maria Raiola, et al.
Haematologica|January 18, 2020
Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working PartyJoerg Henes, Maria Carolina Oliveira, Myriam Labopin, et al.
Blood|December 10, 2008
Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di MidolloBenedetto Bruno, Marcello Rotta, Francesca Patriarca, et al.
Blood Advances|July 15, 2024
Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasmsYves Chalandon, Diderik-Jan Eikema, Ivan Moiseev, et al.
Bone Marrow Transplantation|June 2, 2026
HLA matching in contemporary haematopoietic cell transplantation: Recommendations from the EBMT Practice Harmonisation and Guidelines CommitteeEsteban Arrieta-Bolaños, Alberto Cardoso Martins Lima, Marco Andreani, et al.
Pageof 14